openPR Logo
Press release

Cancer Stem Cells Market Expected to Witness Significant Growth and Reach 4.5 Billion by 2031 Due to Rising Demand for Effective Cancer Treatments

04-08-2025 12:14 PM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

Cancer Stem Cells Market

Cancer Stem Cells Market

According to the latest research by InsightAce Analytic, the Global Cancer Stem Cells Market is valued at US$ 2.1 Bn in 2023, and it is expected to reach US$ 4.5 Bn by 2031, with a CAGR of 9.7% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2476

Cancer stem cells represent a distinct subset of tumor cells with the ability to differentiate into various cell types, exhibiting characteristics similar to those of normal stem cells. The global cancer stem cell market is witnessing notable growth, fueled by the rising incidence of cancer, expanding research and development (R&D) activities, and the increasing acceptance of stem cell-based therapies. Various international organizations are actively involved in research collaborations aimed at improving the application and effectiveness of cancer stem cell therapies.

However, several challenges could impede market expansion during the forecast period. Regulatory hurdles related to the approval and clinical application of stem cell therapies pose significant obstacles to market progress. Additionally, the complexities involved in the manufacturing and pharmacological development of stem cell-based treatments may further slow the market's advancement. Despite these challenges, the growing global burden of cancer underscores the critical need for safe and effective treatments that can target all cancer cells and minimize the risk of recurrence. This rising demand has led to a substantial increase in research funding and the development of innovative therapeutic approaches, which are expected to drive the continued growth of the cancer stem cell market in the coming years.

Recent Developments:
• In April 2024, STEMCELL Technologies is proud to announce that the U.S. Food and Drug Administration officially classified their innovative EasySepTM Human Bone Marrow CD138 Positive Selection Kit as a groundbreaking in vitro diagnostic medical device for hematopoietic cell enrichment.
• In March 2024, Merck, a frontrunner in the scientific and technological industries, introduced the world to the first comprehensive, laboratory-validated genetic stability test. Accelerating biosafety assessment and the transition into commercial production, the AptegraTM CHO genetic stability assay utilizes whole genome sequencing and bioinformatics.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

List of Prominent Players in the Cancer Stem Cells Market:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• STEMCELL Technologies Inc.
• Sino Biological Inc.
• Celgene Corporation
• AbbVie Inc.
• Incyte Corporation
• Novartis AG
• Pfizer Inc.
• Bionique Testing Laboratories Inc.
• Miltenyi Biotec GmbH
• Lonza Group AG
• OncoMed Pharmaceuticals Inc.
• Daiichi Sankyo Company Limited
• Verastem Inc.
• Other Prominent Players

Market Drivers: Increased Demand for Advanced Cancer Treatments
The rising global incidence of cancer is driving a growing need for more effective and long-lasting treatment options, thus propelling the demand for cancer stem cell-based therapies. Research into cancer stem cells is pivotal in addressing this demand by providing innovative approaches to target cancer at its foundational level. Additionally, the increasing adoption of personalized medicine, which focuses on customized treatment plans based on individual patient characteristics, highlights the crucial role of cancer stem cell research in enhancing drug targeting and advancing biomarker discovery. Breakthroughs in cellular and molecular biology have further refined the study of cancer stem cells, enabling more precise and comprehensive research, and opening up new opportunities for their integration into cancer therapies. These developments are contributing to the significant expansion of the market.

Market Challenges: Complex Regulatory Approval Pathways
The advancement of cancer stem cell-based therapies encounters substantial challenges due to the intricate and time-consuming regulatory approval processes. Understanding the complex mechanisms and interactions of cancer stem cells within tumors requires sophisticated technological tools and extensive, iterative research, resulting in high costs associated with demonstrating the safety and efficacy of these treatments. Additionally, the novel mechanisms of action associated with cancer stem cell-targeted therapies raise concerns about the potential impact on normal stem cells, which could hinder market growth. A primary challenge lies in the identification and isolation of cancer stem cells, as their similarities to normal stem cells make it difficult to distinguish and selectively target cancerous cells without affecting healthy stem cell populations, thus posing a significant barrier to clinical advancement.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2476

Regional Trends: North America Expected to Exhibit the Highest Growth Rate During the Forecast Period
The North American cancer stem cell market is expected to capture a significant share of the global revenue, with a projected high compound annual growth rate (CAGR) in the coming years. This growth is supported by a well-established healthcare infrastructure, a substantial number of research institutions dedicated to the development of stem cell therapies, and the increasing prevalence of various cancers. Furthermore, Europe is expected to retain a strong market position, driven by rapid urbanization, enhanced healthcare facilities, and higher disposable incomes. The rising incidence of breast cancer in the region, largely attributed to lifestyle factors such as reduced physical activity and increased alcohol consumption, is further fueling the growth of the cancer stem cell market in Europe.

Segmentation of Cancer Stem Cells Market-
Cancer Stem Cells Market- By Type of Cancer
• Breast Cancer
• Lung Cancer
• Brain Cancer
• Prostate Cancer
• Colorectal Cancer
• Others
Cancer Stem Cells Market- By Treatment Type
• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Stem Cell Transplantation
• Others
Cancer Stem Cells Market- By Biomarker Type
• CD44
• CD133
• ALDH1
• Others
Cancer Stem Cells Market- By End-user
• Hospitals
• Cancer Research Institutes
• Biotechnology Companies
• Academic Research Institutes
Cancer Stem Cells Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Stem Cells Market Expected to Witness Significant Growth and Reach 4.5 Billion by 2031 Due to Rising Demand for Effective Cancer Treatments here

News-ID: 3960478 • Views:

More Releases from Insightace Analytic Pvt Ltd.

4PL Logistics Market Revenue Report with Forecast to 2034
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1609 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global 4PL Logistics Market are: • Rapid growth of automotive the
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to 2034
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034" The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period. Request For Free Sample Pages:
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For